Erasmus MC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Erasmus MC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013281
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemistry, biomedical engineering, biomedical science, cellular biology, dermatology, molecular genetics, oncology, immunology, cardiology, gastroenterology and hepatology, immunology, neuroscience, radiotherapy, rehabilitation; ear, nose and throat problems, gynecology, pathology, hematology, and others. The institute offers patient care, education and research services through its network of hospitals located across the Netherlands. Erasmus is headquartered in Rotterdam, Noord-Holland, the Netherlands.

Erasmus MC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Erasmus MC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Erasmus MC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Erasmus MC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Erasmus MC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Erasmus MC, Medical Devices Deals, 2011 to YTD 2017 9
Erasmus MC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Erasmus MC, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Gilde Healthcare Acquires Majority Stake In Viroclinics Biosciences From Erasmus MC 11
Partnerships 12
MdxHealth Enters into Agreement with Erasmus MC 12
Ingenuity Systems Enters Into Co-Development Agreement With Erasmus University 13
Licensing Agreements 14
Advanced Accelerator Applications Enters into Licensing Agreement with Erasmus University Medical Center and Demokritos National Center 14
Erasmus MC – Key Competitors 15
Erasmus MC – Key Employees 16
Erasmus MC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Oct 06, 2016: Erasmus MC: Ear infection is in your DNA 18
Jul 28, 2016: Erasmus MC: Zika virus active in early pregnancy 19
Jul 25, 2016: CSL Behring Awards Emerging Coagulation Specialists Across the Globe to Support Advancements in the Care of Patients with Bleeding Disorders 20
Feb 16, 2016: Erasmus MC: Aggression linked to SSRIs not due to lack of enzyme 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Erasmus MC, Pharmaceuticals & Healthcare, Key Facts 2
Erasmus MC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Erasmus MC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Erasmus MC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Erasmus MC, Deals By Therapy Area, 2011 to YTD 2017 8
Erasmus MC, Medical Devices Deals, 2011 to YTD 2017 9
Erasmus MC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Gilde Healthcare Acquires Majority Stake In Viroclinics Biosciences From Erasmus MC 11
MdxHealth Enters into Agreement with Erasmus MC 12
Ingenuity Systems Enters Into Co-Development Agreement With Erasmus University 13
Advanced Accelerator Applications Enters into Licensing Agreement with Erasmus University Medical Center and Demokritos National Center 14
Erasmus MC, Key Competitors 15
Erasmus MC, Key Employees 16
Erasmus MC, Other Locations 17
Erasmus MC, Subsidiaries 17

★海外企業調査レポート[Erasmus MC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Kansai Electric Power Company Inc:発電所・企業SWOT分析
    The Kansai Electric Power Company Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Haemonetics Corp (HAE):企業の財務・戦略的SWOT分析
    Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Hopewell Holdings Ltd (54):企業の財務・戦略的SWOT分析
    Hopewell Holdings Ltd (54) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company offers products such as InsuPad and InsuPatch which are designed to improve the current meal-time insulin therap …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Haitong Securities Co., Ltd.:戦略・SWOT・企業財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sonoma Pharmaceuticals Inc (SNOA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Ellomay Capital Ltd (ELLO):企業の財務・戦略的SWOT分析
    Summary Ellomay Capital Ltd (Ellomay), formerly NUR Macroprinters Ltd, is an energy and infrastructure consulting company that provides renewable energy, oil and gas exploration, and clean energy solutions. The company offers renewable energy services such as installation of photovoltaic plants, man …
  • Duskin Co Ltd:企業の戦略・SWOT・財務情報
    Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Advent Capital (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Santen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis co …
  • Jindal Hotels Ltd:企業の戦略・SWOT・財務情報
    Jindal Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Jindal Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • Intrinsic Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery; prosthesis for partial anulus replacement; and anular clos …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Illinois Tool Works Inc.:企業の戦略・SWOT・財務情報
    Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report Summary Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • OrthoPediatrics Corp (KIDS):医療機器:M&Aディール及び事業提携情報
    Summary OrthoPediatrics Corp (OrthoPediatrics) is a medical device company that designs, develops and distributes implants and instruments. The company offers trauma and deformity, spine, sports medicine, and clinical education products. It provides cannulated screws, spine system, ACL reconstructio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆